索尼和WS Audiology推出FDA批准的,非经销商的CRE-C20助听器,用于成人轻度至中度听力损失. Sony and WS Audiology launch FDA-cleared, OTC CRE-C20 hearing aid for mild to moderate hearing loss in adults.

Sony和WS音频学推出了CRE-C20,这是一个场外助听器(OTC),为18岁及18岁以上的人提供轻度至中度听力损失。 Sony and WS Audiology have launched the CRE-C20, an over-the-counter (OTC) hearing aid designed for individuals aged 18 and older with mild to moderate hearing loss. 该装置的特点是先进的音响技术、可再充电电池便利和高度定制的用户经验,所有这些设计几乎几乎是无形的。 The device features advanced sound technology, rechargeable battery convenience, and a highly customizable user experience, all in a nearly invisible design. CRE-C20旨在在不同环境中提供可靠的支持,提高听力清晰度,并提供强大的电池,提供长达28小时的持续使用。 The CRE-C20 aims to provide reliable support and enhanced hearing clarity in various environments, and offers a powerful battery offering up to 28 hours of continuous use. 助听器经过FDA批准,符合FSA/HSA资格,可通过各种零售商购买,包括索尼,百思买,亚马逊,沃尔玛,CVS.com,HearUSA和一些听力护理机构. The hearing aid is FDA-cleared and FSA/HSA eligible, and is available through various retailers including Sony, Best Buy, Amazon, Walmart, CVS.com, HearUSA, and some hearing care places.